Milestone Pharmaceuticals Inc [NASDAQ: MIST] traded at a low on Friday, posting a -60.89 loss after which it closed the day’ session at $0.88.
The results of the trading session contributed to over 33293526 shares changing hands. Over the past one week, the price volatility of Milestone Pharmaceuticals Inc stands at 25.86% while the volatility over the past one month is 15.12%.
The market cap for MIST stock reached $46.95 million, with 53.35 million shares outstanding and 50.79 million shares in the current float. Compared to the average trading volume of 1.56M shares, MIST reached a trading volume of 33293526 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Milestone Pharmaceuticals Inc [MIST]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MIST shares is $8.80 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MIST stock is a recommendation set at 1.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Rodman & Renshaw have made an estimate for Milestone Pharmaceuticals Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 22, 2024. While these analysts kept the previous recommendation, Jefferies dropped their target price from $8 to $4. The new note on the price target was released on June 20, 2023, representing the official price target for Milestone Pharmaceuticals Inc stock. Previously, the target price had yet another raise from $8 to $10, while Piper Sandler kept a Overweight rating on MIST stock.
The Average True Range (ATR) for Milestone Pharmaceuticals Inc is set at 0.31 The Price to Book ratio for the last quarter was 3.57, with the Price to Cash per share for the same quarter was set at 1.31.
How has MIST stock performed recently?
Milestone Pharmaceuticals Inc [MIST] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -53.68. With this latest performance, MIST shares dropped by -49.43% in over the last four-week period, additionally sinking by -41.72% over the last 6 months – not to mention a drop of -51.38% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MIST stock in for the last two-week period is set at 30.59, with the RSI for the last a single of trading hit 26.67, and the three-weeks RSI is set at 33.38 for Milestone Pharmaceuticals Inc [MIST]. The present Moving Average for the last 50 days of trading for this stock 1.9906, while it was recorded at 1.8140 for the last single week of trading, and 1.6966 for the last 200 days.
Milestone Pharmaceuticals Inc [MIST]: Deeper insight into the fundamentals
Milestone Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 9.10 and a Current Ratio set at 9.10.
Earnings analysis for Milestone Pharmaceuticals Inc [MIST]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MIST. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Milestone Pharmaceuticals Inc go to -7.26%.
Insider trade positions for Milestone Pharmaceuticals Inc [MIST]
There are presently around $46.69%, or 47.00%% of MIST stock, in the hands of institutional investors. The top three institutional holders of MIST stocks are: BLACKROCK INC. with ownership of 4.97 million shares, which is approximately 7.5135%. RTW INVESTMENTS, LP, holding 3.26 million shares of the stock with an approximate value of $$4.3 million in MIST stocks shares; and RTW INVESTMENTS, LP, currently with $$3.66 million in MIST stock with ownership which is approximately 4.1561%.
